|
|
|
Fiscal Period: December
|
2017 |
2018 |
2019 |
2020 |
2021 |
2022 |
| Capitalization1 |
263 | 271 | 192 | 350 | 350 | - |
| Entreprise Value (EV)1 |
263 | 271 | 192 | 350 | 350 | 350 |
| P/E ratio |
-4,58x | -15,7x | -125x | 61,2x | 24,2x | 25,5x |
| Yield |
- | - | - | - | - | - |
| Capitalization / Revenue |
1,19x | 1,08x | 0,68x | 1,12x | 1,02x | 0,95x |
| EV / Revenue |
1,19x | 1,08x | 0,68x | 1,12x | 1,02x | 0,95x |
| EV / EBITDA |
10,8x | 6,15x | 5,54x | 8,52x | 7,77x | 6,86x |
| Price to Book |
- | - | - | - | - | - |
| Nbr of stocks (in thousands) |
59 677 | 75 291 | 76 810 | 76 335 | 76 335 | - |
| Reference price (USD) |
4,40 | 3,60 | 2,50 | 4,59 | 4,59 | 4,59 |
| Last update |
03/14/2018 | 03/13/2019 | 03/13/2020 | - | - | - |
|
1 Estimates
|
|
| Income Statement Evolution | |
|
|
|
| Annual Income Statement Data |
|
|
Fiscal Period: December
|
2017 |
2018 |
2019 |
2020 |
2021 |
2022 |
| Net sales1 |
220 | 250 | 282 | 314 | 344 | 369 |
| EBITDA1 |
24,2 | 44,1 | 34,7 | 41,1 | 45,1 | 51,1 |
| Operating profit (EBIT)1 |
-42,5 | 11,4 | 5,22 | 11,4 | 20,7 | 25,7 |
| Operating Margin |
-19,3% | 4,54% | 1,85% | 3,63% | 6,02% | 6,96% |
| Pre-Tax Profit (EBT)1 |
-53,2 | 3,24 | -1,67 | 5,95 | 15,4 | 21,4 |
| Net income1 |
-53,2 | -17,9 | -1,75 | 6,12 | 15,2 | 21,0 |
| Net margin |
-24,2% | -7,16% | -0,62% | 1,95% | 4,43% | 5,70% |
| EPS2 |
-0,96 | -0,23 | -0,02 | 0,08 | 0,19 | 0,18 |
| Dividend per Share |
- | - | - | - | - | - |
| Last update |
03/14/2018 | 03/13/2019 | 03/13/2020 | - | - | - |
|
1 USD in Million 2 USD Estimates
|
|
|
|
|
Fiscal Period: December
|
2017 |
2018 |
2019 |
2020 |
2021 |
2022 |
| Net Debt |
- | - | - | - | - | - |
| Net Cash position |
- | - | - | - | - | - |
| Leverage (Debt / EBITDA) |
- | - | - | - | - | - |
| Free Cash Flow |
- | - | - | - | - | - |
| ROE (Net Profit / Equities) |
- | - | - | - | - | - |
| Shareholders' equity1 |
- | - | - | - | - | - |
| ROA (Net Profit / Asset) |
- | - | - | - | - | - |
| Assets1 |
- | - | - | - | - | - |
| Book Value Per Share |
- | - | - | - | - | - |
| Cash Flow per Share |
- | - | - | - | - | - |
| Capex |
- | - | - | - | - | - |
| Capex / Sales |
- | - | - | - | - | - |
| Last update |
03/14/2018 | 03/13/2019 | 03/13/2020 | 11/02/2020 | 11/02/2020 | 11/02/2020 |
|
1 USD in Million Estimates
|
|
|
|
|
|
Financial data source
© 2021 S&P Global Market Intelligence
|
|
|
Insurers look to curb ransomware exposure as U.S. cyber rates rise |
Capitalization (USD) 350 376 888 Net sales (USD) 281 684 000 Sales / Employee (USD) 1 482 547 Free-Float capitalization (USD) 179 643 994 Avg. Exchange 20 sessions (USD) 4 453 521 Average Daily Capital Traded 1,27%
Year-on-year evolution of the PER
Evolution Valeur d'Entreprise / EBITDA
|
Canada
Deutschland
España
France
Italia
Schweiz (DE)
United Kingdom
Report
